IART in the 13F filings
Integra Lifesciences Holdings Corp · CUSIP 457985208
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 0 listed it in both
- Shares listed
- 11,577,448
- combined, among listed positions
- Reported value
- $207m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +712,321.
Managers listing IART in Q2 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 1,439,747 shares now+816,894
- Invesco Ltdexisting position · 3,749,367 shares now+263,764
- Neuberger Berman Group LLCexisting position · 2,364,777 shares now+249,522
- Marshall Wace LLPexisting position · 349,737 shares now+176,254
- Wellington Management Group LLPexisting position · 1,461,104 shares now+160,814
Reductions
- Voloridge Investment Management LLCexisting position · 79,689 shares now-173,215
- Balyasny Asset Management LLCexisting position · 640,666 shares now-53,410
- Two Sigma Investments LPexisting position · 184,955 shares now-27,755
- AllianceBernstein LPexisting position · 97,950 shares now-1,600
New positions and exits
New (4)
Exited (8)
- Citadel Advisors LLCwas $4.5m
- ExodusPoint Capital Management LPwas $2.3m
- Walleye Capital LLCwas $2.1m
- Jane Street Group LLCwas $1.5m
- Maverick Capital Ltdwas $679k
- Brevan Howard Capital Management LPwas $474k
- Verition Fund Management LLCwas $161k
- Freestone Grove Partners LPwas $0
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 1 | $447k | n.a. | n.a. |
| Q3 2013 | 2 | $523k | n.a. | n.a. |
| Q4 2013 | 1 | $587k | n.a. | n.a. |
| Q1 2015 | 2 | $13m | n.a. | n.a. |
| Q2 2015 | 2 | $347m | n.a. | n.a. |
| Q3 2015 | 5 | $370m | n.a. | n.a. |
| Q4 2015 | 3 | $408m | n.a. | n.a. |
| Q1 2016 | 4 | $378m | n.a. | n.a. |
| Q2 2016 | 5 | $494m | n.a. | n.a. |
| Q3 2016 | 4 | $550m | n.a. | n.a. |
| Q4 2016 | 8 | $639m | n.a. | n.a. |
| Q1 2017 | 9 | $472m | n.a. | n.a. |
| Q2 2017 | 6 | $823m | n.a. | n.a. |
| Q3 2017 | 5 | $963m | n.a. | n.a. |
| Q4 2017 | 3 | $999m | n.a. | n.a. |
| Q1 2018 | 3 | $1.2bn | n.a. | n.a. |
| Q2 2018 | 10 | $1.7bn | n.a. | n.a. |
| Q3 2018 | 6 | $1.9bn | n.a. | n.a. |
| Q4 2018 | 7 | $1.1bn | n.a. | n.a. |
| Q1 2019 | 8 | $986m | n.a. | n.a. |
| Q2 2019 | 7 | $1.1bn | n.a. | n.a. |
| Q3 2019 | 5 | $1.1bn | n.a. | n.a. |
| Q4 2019 | 5 | $1.1bn | n.a. | n.a. |
| Q1 2020 | 7 | $855m | n.a. | n.a. |
| Q2 2020 | 5 | $892m | n.a. | n.a. |
| Q3 2020 | 6 | $992m | n.a. | n.a. |
| Q4 2020 | 6 | $1.4bn | n.a. | n.a. |
| Q1 2021 | 4 | $1.5bn | n.a. | n.a. |
| Q2 2021 | 6 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 6 | $1.7bn | n.a. | n.a. |
| Q4 2021 | 6 | $1.6bn | n.a. | n.a. |
| Q1 2022 | 8 | $1.3bn | n.a. | n.a. |
| Q2 2022 | 10 | $969m | n.a. | n.a. |
| Q3 2022 | 14 | $702m | n.a. | n.a. |
| Q4 2022 | 11 | $946m | n.a. | n.a. |
| Q1 2023 | 11 | $864m | n.a. | n.a. |
| Q2 2023 | 12 | $492m | n.a. | n.a. |
| Q3 2023 | 13 | $481m | n.a. | n.a. |
| Q4 2023 | 10 | $530m | 5 | 6 |
| Q1 2024 | 8 | $378m | 7 | 2 |
| Q2 2024 | 6 | $212m | 3 | 4 |
| Q3 2024 | 3 | $87m | 2 | 1 |
| Q4 2024 | 3 | $60m | 2 | 2 |
| Q1 2025 | 3 | $34m | 1 | 2 |
| Q2 2025 | 2 | $2.8m | 1 | 2 |
| Q3 2025 | 2 | $1.8m | 0 | 2 |
| Q4 2025 | 1 | $662k | 13 | 11 |
| Q1 2026 | 1 | $679k | 13 | 11 |
| Q2 2026 | 1 | $1.8m | 14 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IART and LLY →IART and JNJ →IART and VRTX →Choose a stock to compare with IART →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IART, latest filings →Back to the 13F Explorer →